Immune Checkpoint Inhibitor as a Fifth Component of Lipid Nanoparticles Enables Lymph Node‐Targeting and Augments mRNA Vaccine Efficacy
Minki Ha, Jaehyun Kim, Seyoung Kim, Gonna Somu Naidu, Sungchan Cho, Seok‐Beom Yong · 2026
Read Immune Checkpoint Inhibitor as a Fifth Component of Lipid Nanoparticles Enables Lymph Node‐Targeting and Augments mRNA Vaccine Efficacy by Minki Ha, Jaehyun Kim, Seyoung Kim, Gonna Somu Naidu, Sungchan Cho, Seok‐Beom Yong (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13616246.txt.
Description
Minki Ha and colleagues report a twist on the lipid nanoparticle carriers that deliver mRNA vaccines. Adding an immune checkpoint blocker as a fifth ingredient steers the particles to lymph nodes. It also strengthens the vaccine. Standard carriers use four lipids, and newer designs add a fifth to tune where they go. The team's fifth piece is a two-ringed, water-and-fat-loving molecule that blocks PD-L1, an immune brake.
Particles with the new ingredient produced nearly seven times more mRNA expression in the groin lymph node, the immune hub where responses are organised. Treated nodes swelled with immune cells, and vaccine effect rose with them. Sending the message and a brake release to the same address in one particle points toward cancer vaccines that work harder at lower doses.
Catalog record
| CREATOR | Minki Ha, Jaehyun Kim, Seyoung Kim, Gonna Somu Naidu, Sungchan Cho, Seok‐Beom Yong |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 36 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |